⚠️ Safety Alert:
Patients on busulfan should seek urgent medical advice if their temperature rises above 37.5°C (99.5°F) or 38°C (100.4°F), or if they feel unwell (e.g., chills, sore throat, cough, diarrhoea, frequent urination).
👉 Even mild infections can rapidly become serious due to immunosuppression.
💊 About
- Busulfan is an alkylating agent used in haematological malignancies.
- Causes DNA cross-links and breaks → inhibits replication and triggers apoptosis.
- Always check the BNF entry before prescribing.
⚙️ Mode of Action
- Forms covalent bonds with DNA, causing double-strand breaks and cross-linking.
- Non–cell cycle specific but most active in rapidly dividing cells.
🎯 Indications / Dose
- Chronic myeloid leukaemia (CML).
- Multiple myeloma.
- Part of conditioning regimens before haematopoietic stem cell transplantation.
🤝 Interactions
- See BNF for full list.
- Notably interacts with paracetamol (alters clearance) and phenytoin (induces metabolism).
⚠️ Cautions
- High risk of dosing errors with oral anti-cancer medicines → must follow protocols strictly.
- Seizure risk: prophylactic anticonvulsants (e.g., levetiracetam) often recommended in transplant regimens.
- Monitor blood counts, LFTs, and pulmonary function closely.
🚫 Contraindications
- Acute porphyrias.
- Severe hepatic impairment (relative contraindication).
❗ Side Effects
- Bone marrow suppression → neutropenia, anaemia, thrombocytopenia.
- Pulmonary toxicity (“busulfan lung”: interstitial fibrosis, restrictive lung disease).
- Hepatic veno-occlusive disease (especially post-transplant conditioning).
- Skin pigmentation (“busulfan tan”).
- Nausea, vomiting, mucositis.
- Seizures at high doses.
📚 References